598 related articles for article (PubMed ID: 23731532)
21. Apremilast for the treatment of psoriatic arthritis.
Souto A; Gómez-Reino JJ
Expert Rev Clin Immunol; 2015; 11(12):1281-90. PubMed ID: 26503917
[TBL] [Abstract][Full Text] [Related]
22. Distinguishing inflammatory from noninflammatory arthritis, enthesitis, and dactylitis in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.
Mease PJ
J Rheumatol; 2012 Feb; 39(2):415-7. PubMed ID: 22298269
[TBL] [Abstract][Full Text] [Related]
23. The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development.
Aydin SZ; Ash ZR; Tinazzi I; Castillo-Gallego C; Kwok C; Wilson C; Goodfield M; Gisondi P; Tan AL; Marzo-Ortega H; Emery P; Wakefield RJ; McGonagle DG
Ann Rheum Dis; 2013 Jun; 72(6):992-5. PubMed ID: 22863575
[TBL] [Abstract][Full Text] [Related]
24. Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes.
McInnes IB; Sawyer LM; Markus K; LeReun C; Sabry-Grant C; Helliwell PS
RMD Open; 2022 Mar; 8(1):. PubMed ID: 35321874
[TBL] [Abstract][Full Text] [Related]
25. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.
Coates LC; Kavanaugh A; Mease PJ; Soriano ER; Laura Acosta-Felquer M; Armstrong AW; Bautista-Molano W; Boehncke WH; Campbell W; Cauli A; Espinoza LR; FitzGerald O; Gladman DD; Gottlieb A; Helliwell PS; Husni ME; Love TJ; Lubrano E; McHugh N; Nash P; Ogdie A; Orbai AM; Parkinson A; O'Sullivan D; Rosen CF; Schwartzman S; Siegel EL; Toloza S; Tuong W; Ritchlin CT
Arthritis Rheumatol; 2016 May; 68(5):1060-71. PubMed ID: 26749174
[TBL] [Abstract][Full Text] [Related]
26. Current concepts and new developments in the treatment of psoriatic arthritis.
Pipitone N; Kingsley GH; Manzo A; Scott DL; Pitzalis C
Rheumatology (Oxford); 2003 Oct; 42(10):1138-48. PubMed ID: 12810935
[TBL] [Abstract][Full Text] [Related]
27. Leflunomide in psoriatic arthritis.
Kaltwasser JP
Autoimmun Rev; 2007 Sep; 6(8):511-4. PubMed ID: 17854740
[TBL] [Abstract][Full Text] [Related]
28. Methotrexate achieves major cDAPSA response, and improvement in dactylitis and functional status in psoriatic arthritis.
Appani SK; Devarasetti PK; Irlapati RVP; Rajasekhar L
Rheumatology (Oxford); 2019 May; 58(5):869-873. PubMed ID: 30590763
[TBL] [Abstract][Full Text] [Related]
29. Active peripheral inflammation is associated with pro-atherogenic lipid profile in psoriatic arthritis.
Shrestha A; Bahce-Altuntas A; Mowrey W; Broder A
Semin Arthritis Rheum; 2016 Dec; 46(3):286-290. PubMed ID: 27373499
[TBL] [Abstract][Full Text] [Related]
30. Therapies for psoriatic enthesopathy. A systematic review.
Ritchlin CT
J Rheumatol; 2006 Jul; 33(7):1435-8. PubMed ID: 16724370
[TBL] [Abstract][Full Text] [Related]
31. Psoriatic arthritis for the dermatologist.
Tintle SJ; Gottlieb AB
Dermatol Clin; 2015 Jan; 33(1):127-48. PubMed ID: 25412788
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Dactylitis and Enthesitis in Psoriatic Arthritis with Biologic Agents: A Systematic Review and Metaanalysis.
Mourad A; Gniadecki R
J Rheumatol; 2020 Jan; 47(1):59-65. PubMed ID: 30824641
[TBL] [Abstract][Full Text] [Related]
33. Psoriatic arthritis: update on pathophysiology, assessment and management.
Mease PJ
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i77-84. PubMed ID: 21339225
[TBL] [Abstract][Full Text] [Related]
34. Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis.
Rahman P; McInnes IB; Deodhar A; Schett G; Mease PJ; Shawi M; Cua DJ; Sherlock JP; Kollmeier AP; Xu XL; Sheng S; Ritchlin CT; McGonagle D
Clin Rheumatol; 2024 May; 43(5):1591-1604. PubMed ID: 38472528
[TBL] [Abstract][Full Text] [Related]
35. Juvenile psoriatic arthritis and comorbidities: report of a case associated with enthesitis and celiac disease.
Prignano F; Bonciani D; Bandinelli F; Matucci Cerinic M; Lotti T
Dermatol Ther; 2010; 23 Suppl 2():S47-50. PubMed ID: 20482570
[TBL] [Abstract][Full Text] [Related]
36. Dactylitis is an indicator of a more severe phenotype independently associated with greater SJC, CRP, ultrasound synovitis and erosive damage in DMARD-naive early psoriatic arthritis.
Dubash S; Alabas OA; Michelena X; Garcia-Montoya L; Wakefield RJ; Helliwell PS; Emery P; McGonagle DG; Tan AL; Marzo-Ortega H
Ann Rheum Dis; 2022 Apr; 81(4):490-495. PubMed ID: 34893470
[TBL] [Abstract][Full Text] [Related]
37. Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis.
Gladman DD; Orbai AM; Klitz U; Wei JC; Gallo G; Birt J; Rathmann S; Shrom D; Marzo-Ortega H
Arthritis Res Ther; 2019 Jan; 21(1):38. PubMed ID: 30696483
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive treatment of dactylitis in psoriatic arthritis.
Rose S; Toloza S; Bautista-Molano W; Helliwell PS;
J Rheumatol; 2014 Nov; 41(11):2295-300. PubMed ID: 25362714
[TBL] [Abstract][Full Text] [Related]
39. Enthesitis in patients with psoriatic arthritis: A nationwide data from the Chinese Registry of Psoriatic Arthritis (CREPAR).
Yang F; Lu C; Liu H; Dou L; Wang Y; Li H; Duan X; Wu L; Wang Y; Zhang X; Xu J; Su J; Xu D; Zhao J; Wu Q; Li M; Leng X; Zeng X
Chin Med J (Engl); 2023 Apr; 136(8):951-958. PubMed ID: 37036901
[TBL] [Abstract][Full Text] [Related]
40. Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes.
Simons N; Degboé Y; Barnetche T; Cantagrel A; Ruyssen-Witrand A; Constantin A
Clin Exp Rheumatol; 2020; 38(3):508-515. PubMed ID: 31969228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
